9 results

• Trulicity, Byetta, Victoza, Similar Diabetes Drugs Do Not Appear to Increase Breast Cancer Risks: Study

  March 25, 2021

  Martha Garcia

  A new study finds no link between popular diabetes drugs like Byetta and Trulicity, and an increased risk of breast cancer.

• Invokana, Farxiga Problems Renew Concerns About Direct-to-Consumer Advertisements

  August 14, 2015

  Austin Kirk

  Amid recent safety questions, concerns have emerged about direct-to-consumer advertisements for Invokana and similar drugs that include off-label marketing weight loss claims.

• Byetta Settlements Reached in 84 Cases, But Hundreds of Lawsuits Remain

  August 8, 2014

  Austin Kirk

  AstraZeneca announced it has settled 84 Byetta lawsuits, but still faces more than 400 claims involving allegations that the diabetes drug caused pancreatic cancer, thyroid cancer or pancreatitis.

• Bydureon Side Effects Linked to Injection Site Reactions

  June 17, 2014

  Irvin Jackson

  Bydureon, a long-acting version of Byetta, has been linked to severe injection site reactions, the FDA warns.

• AstraZeneca Buys Bristol-Myers Squibb Diabetes Interests, Byetta

  February 11, 2014

  Irvin Jackson

  AstraZeneca has agreed to buy all of Bristol-Myers Squibb's diabetes drug interests, as a growing number of Byetta, Bydureon and Ongylza lawsuits continue to be filed by former users of the incretin mimetics diagnosed with cancer.

• Pancreatic Cancer Wrongful Death Lawsuit Filed Over Diabetes Drugs

  May 16, 2013

  Irvin Jackson

  A wrongful death lawsuit has been filed by the family of a California woman, which alleges that their mother developed...

• Januvia, Byetta Pancreatic Cancer Risk Review Launched by FDA

  March 15, 2013

  Austin Kirk

  The FDA has launched an investigating into the possibility that diabetics may face an increased risk of pancreatitis and pancreatic...

• Byetta Heart Risk Information Concealed from FDA: Memo

  June 26, 2012

  Irvin Jackson

  Recently revealed government records suggest that Amylin Pharmaceuticals may have attempted to hide information about the potential risk of heart...

• Side Effects of Byetta, Victoza, Topic of Debate at Conference

  September 14, 2011

  Staff Writers

  Diabetes experts meeting in Lisbon this week are taking a close look at whether a class of long-acting diabetes drugs,...